Genpharmasec promoter Rajesh Sadhwani buys 65 lakh shares
- Rajesh Mirchumal Sadhwani acquired 65,00,000 shares in Genpharmasec Ltd via open market purchases
- His individual stake increased from 14.09% to 15.26% following the transaction
- Combined promoter group holding rose to 32.06% from 30.88%
- No shares were encumbered or pledged by the promoters as per the disclosure
*this image is generated using AI for illustrative purposes only.
Rajesh Mirchumal Sadhwani, a promoter of Genpharmasec Ltd , acquired 65,00,000 equity shares through the open market on August 31 and September 1, 2026. The purchase increased his individual holding to 15.26% of the company’s total share capital.
The acquisition was disclosed under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Sadhwani holds these shares alongside Sneha Sadhwani, who is designated as a Person Acting in Concert (PAC). Neither party reported any encumbrances, pledges, or liens on their holdings.
Shareholding Structure Changes
Before this transaction, Rajesh Mirchumal Sadhwani held 7,80,00,000 shares, representing 14.09% of the total voting capital. Sneha Sadhwani held 9,30,01,000 shares, accounting for 16.80%. Together, the promoter group controlled 30.88% of the company.
Following the open market purchases, Sadhwani’s stake rose to 8,45,00,000 shares. The combined holding of the promoter group increased to 17,75,01,000 shares, or 32.06% of the total diluted share capital. The company’s total equity share capital remains unchanged at ₹55,37,19,700, divided into 55,37,19,700 equity shares of Re. 1 each.
| Metric | Before Acquisition | After Acquisition | Change |
|---|---|---|---|
| Rajesh Sadhwani Holding (%) | 14.09% | 15.26% | +1.17% |
| Sneha Sadhwani Holding (%) | 16.80% | 16.80% | 0.00% |
| Combined Promoter Group (%) | 30.88% | 32.06% | +1.17% |
What the Numbers Show
The acquisition reflects a consolidation of control by the promoter group without altering the overall capital structure. With no convertible securities or warrants outstanding, the fully diluted voting capital matches the basic share capital. The absence of pledged shares indicates that the promoter group’s collateral position has not tightened during this period.
Historical Stock Returns for Genpharmasec
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +4.24% | +23.00% | +18.27% | +4.24% | -36.27% | -75.69% |
How might this consolidation of promoter holding influence Generic Pharmasec Ltd's strategic decisions regarding future capital raises or potential mergers?
Could the open market acquisition signal management confidence in the company's near-term valuation, potentially impacting retail investor sentiment?
Given the absence of pledged shares, how does this strengthen the promoter group's financial flexibility compared to peers in the pharmaceutical sector?
18
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
